Back to Webinars for IRs: What to know for Tumor Board--Metastatic MSK Disease
Developed by SIR's Early Career Section (ECS)
Presented: March 7, 2019
The overall goal of this webinar is to educate IR practitioners in the performance of MSK ablations for metastatic lesions including techniques, outcomes, pitfalls and current literature.
This activity is intended for interventional radiologists and trainees at all levels with special interest in MSK.
As a result of participating in this activity, the learner should be able to:
- Understand the common specialties involved in treatment of MSK metastatic cancer
- Demonstrate an understanding of current literature pertaining to MSK metastatic cancer ablation
- Describe the standard procedural techniques and ways to minimize complications during performance of MSk ablation.
Trevor Downing, MD; Wake Forest University
Shamar Young, MD; University of Minnesota
Matthew Callstrom, MD, PhD; Mayo Clinic
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME). The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide medical education for physicians.
SIR designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program will be approved for a maximum of 1.00 self-assessment CME credits (SA-CME) by the Society of Interventional Radiology (SIR). SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME offered within this enduring material meet the ABR’s criteria for a self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.